CD8A and neoplasm: CD8+ T cells play a crucial role in mediating antitumor immunity, and their effector cells—CD8+ CTLs—recognize tumor-associated antigens presented by major histocompatibility complex I molecules by expressing T-cell receptors to clear tumor cells (Fu and Jiang, 2018).